Emmaus Medical, Inc.
Emmaus Medical, Inc., headquartered in the United States, is a pioneering company in the biopharmaceutical industry, specialising in innovative treatments for rare diseases. Founded in 2008, Emmaus has made significant strides in developing therapies that address unmet medical needs, particularly in the field of sickle cell disease.
The company’s flagship product, Endari, is a unique L-glutamine oral powder that has been clinically proven to reduce complications associated with sickle cell disease. This groundbreaking treatment has positioned Emmaus Medical as a leader in the market, with a commitment to improving patient outcomes and quality of life.
With a strong operational presence across the US and expanding internationally, Emmaus Medical continues to achieve notable milestones, reinforcing its reputation as a trusted provider of specialised medical solutions.
-20 vs industry average
Emmaus Medical, Inc.’s score of 18 is lower than 31% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Emmaus Medical, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Emmaus Medical, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Emmaus Medical, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Emmaus Medical, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project